Browsing eNauka

Browsing by Author Horban, A.

Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)TypeМ-cat.
2005A novel primeboost immunotherapy induces high levels of HBeAg loss after 14 weeks in patients with HBeAg plus chronic hepatitis B - a phase IIA clinical trialHalota, W.; Delić, Dragan; Nešić, Zorica  ; Prokopowicz, D.; Flisiak, R.; Kuydowicz, I.; Jablkowski, I.; Cianciara, J.; Mach, T.; Modrzewska, R.;
Fabri, Miklos; Sad, N.; Tomić, Dragan; Horban, A.; Kryczka, W.; Schneider, J.; Pearce, G.;
Conference Paper
Mp. category will be shown later
2006A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg plus chronic hepatitis B - a phase IIa clinical trialSchneider, J.; Halota, W.; Delić, Dragan; Nešić, Zorica  ; Prokopowicz, D.; Flisiak, R.; Kuydowicz, J.; Jablkowski, M.; Cianciara, J.; Mach, T.;
Modrzewska, R.; Fabri, Miklos; Tomić, Dragan; Horban, A.; Krycka, W.; Cripps, M.;
Conference Paper
Mp. category will be shown later
2006A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B - a phase IIa clinical trialSchneider, J.; Halota, W.; Delić, Dragan; Nešić, Zorica  ; Prokopowicz, D.; Flisiak, R.; Kuydowicz, J.; Jablkowski, M.; Cianciara, J.; Mach, T.;
Modrzewska, R.; Fabri, Miloš; Tomić, Dragan; Horban, A.; Krycka, W.; Cripps, M.;
Conference Paper
Mp. category will be shown later
2006Transmission of drug-resistance in Europe is characterized by single mutations and revertantsWensing, A. M. J.; Vercauteren, J.; van de Vijver, D. A.; Albert, J.; Poggensee, G.; Schmit, J. C.; Struck, D.; Vandamme, A. M.; Asjo, B.; Balotta, C.;
Camacho, R.; Coughlan, S.; Grossman, Z.; Horban, A.; Korn, K.; Nielsen, C.; Paraskevis, D.; Puchhammer-Stockl, E.; Riva, C.; Ruiz, L.; Schuurman, R.; Salminen, M.; Sonnerborg, A.; Stanojević, Maja  ; Boucher, C. A. B.;
Conference Paper
Mp. category will be shown later